NCT02632097 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Amid PK, Lichtenstein IL
Long-term results and current status of the Lichtenstein open tension-free hernioplasty. Hernia 1998; 2: 89-94
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M
The Clavien-Dindo classification of surgical complications: five-year exper
Lichtenstein IL, Shulman AG, Amid PK, Montllor MM
The tension-free hernioplasty. Am J Surg. 1989 Feb;157(2):188-93.

Randomized Prospective Double-Blinded Study of Histoacryl™Mesh Fixation Compared to Conventional Non-absorbable Suture Fixation During Lichtenstein Hernioplasty

Details for clinical trial NCT02632097

Clinical trial NCT02632097 - References